MKI67 and neoplasm: Concordance was significantly influenced by pathological features with relatively high concordance in women with clinical low risk disease, including tumor size ≤ 1 cm, grade 1 or ki67 < 10%, suggesting using OncotypeDX provides no benefit over using PREDICT alone in very low risk disease.